Monthly Archives: January 2014

Self Assessment of Treatment

1  General Information

Instrument Title Self Assessment of Treatment
Description The Self Assessment of Treatment (SAT) questionnaire is a 5-item instrument which was developed to reflect key patient reported outcomes of Neuropathic Pain (NP) treatments in the following areas: evaluating pain, activity level, quality of life (QoL) and satisfaction with treatment (recommend treatment and undergo treatment again).

2  History

Contributor
Author(s): Wyrwich, K.W. , Kawata, A.K., Thompson, C., Holmstrom, S., Stoker, M., Wiklund, I.
Year Created: 2012

3  Cost

Cost No.

4  Classification

Domain

5  Instrument Details

How to access This outcome measure can be obtained by contacting the author at the following e-mail: kathy.wyrwich@unitedbiosource.com

Samples of this outcome measure can be accessed in the following article:

Wyrwich, K.W. , Kawata, A.K., Thompson, C., Holmstrom, S., Stoker, M., Wiklund, I. (2012) Validation of the Self-Assessment of Treatment Questionnaire
among Patients with Postherpetic Neuralgia. Pain Research and Treatment, Volume 2012, Article ID 621619, 15 pages, doi:10.1155/2012/621619

Sample Question(s) (1) How do you assess your pain relief after treatment in this study?
Revision Year 2012
Number of Items 5
Mode of Administration Self
Reliability and Validity References
  1. Wiklund I, Holmstrom S, Stoker M, Wyrwich KW, Devine M. (2013) Are treatment benefits in neuropathic pain reflected in the self assessment of treatment questionnaire? Health Qualilty of Life Outcomes. 2013 Jan 18;11(1):8. [Epub ahead of print]
  2. Wyrwich, K.W. , Kawata, A.K., Thompson, C., Holmstrom, S., Stoker, M., Wiklund, I. (2012) Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia. Pain Research and Treatment, Volume 2012, Article ID 621619, 15 pages, doi:10.1155/2012/621619.
Example CAM Evaluation References We have not found any CAM related references for this outcome measure.
Target Age Group Not specified.
Target Population Patient with peripheral neuropathy.
Time to Administer 5 minutes.
Time Period Assessed Current (based on the recent clinical study).
Translations Available We have not found translation of this outcome measure into any other languages.
Advertisements
%d bloggers like this: